showed that the high expression of FGL-1 was predictive of poor prognosis and was possibly involved in attenuating the therapy effect of anti-PD-1 mAbs; this was related to tumor invasion and metastasis (40), and thus, it was concluded that LAG-3 expression might be associated with anti-PD-1 therapy. Here, FGL1 is linked to neoplasm.